Healthcare >> CEO Interviews >> November 8, 2004


Jay Higham joined IntegraMed in October 1994 as Vice President of Marketing and Development when the company had four locations, $8mm in revenue and a $4mm operating loss focusing exclusively on providing fertility medical services. Mr. Higham was the architect of the company's growth and diversification plan that led the company to over 130 locations, 25% share of the U.S. market for fertility services as well as the largest U.S. group providing varicose vein treatment. Mr. Higham became President & COO in July, 2004 and then President & CEO in January, 2006. In 2008, the company approached $200mm in revenues and over the last five years the company has achieved over 25% compound annual growth rate in net income. Four years prior to joining the Company, Mr. Higham held a variety of executive management positions at various health care service organizations where he developed and implemented strategies for integrating physician practices and managed care payers. From 1987 to 1990, Mr. Higham was a Senior Consultant at Ophnet, Inc., where he focused on practice development, marketing and sales for high technology specialty physician groups. From 1983 to 1987, Mr. Higham held a variety of executive management positions at Carle Clinic Association, a 300 physician multi-specialty group practice. Under Mr. Higham's direction, Carle Clinic expanded its regional presence through aggressive acquisition and new practice start-ups. Profile
TWST: Would you start us off with a short history of IntegraMed and a

brief overview of what you do?

Mr. Higham: In 2005 IntegraMed will be celebrating its 20th year in

business. For the last